Thyrocare Technologies Limited has made a regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30(6) read with Part A of Schedule III.
The company announced the availability of the audio recording of its earnings conference call with analysts and investors that was held on Thursday, July 23, 2026, at 06:00 P.M. IST. The conference call was conducted to discuss the company's unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27).
The audio recording is currently available on the company's investor relations website at https://investor.thyrocare.com/financials/quarterly-financial-results/. The company also indicated that the transcript of the earnings call will be shared shortly.
This disclosure is a continuation of the company's previous communication dated July 16, 2026, and has been signed by Brijesh Kumar, Company Secretary and Compliance Officer of Thyrocare Technologies Limited, with a digital timestamp of July 23, 2026, at 19:28:48 IST.